Purchase of Proteograph reagents ans SP100 Automation Instrument with XT

can-standardContract or concession award notice – standard regime00366541-2026UTUniversity of Turku
Estimated value—
Deadline—
Competition00 participants
Lots11 lot

Keep momentum on this opportunity

Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.

  • Save and reuse search filters
  • Track opportunities as pursuits
  • Get notified when new notices match
Quick actions

Keep this notice in a shortlist so you can return to it without starting a bid.

Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.

Receive alerts

Key information

Identifier
Contract type
—
Deadline
—
CPV codes
24000000 - Chemical products33000000 - Medical equipments, pharmaceuticals and personal care products33600000 - Pharmaceutical products38000000 - Laboratory, optical and precision equipments (excl. glasses)
Status
Awarded
Notice type
can-standardContract or concession award notice – standard regime
Source
Estimated value
—
Publication date
27 May 2026, 22:00

Overview

Turku Bioscience Centre intends to purchase Seer Proteograph reagents for deep discovery proteomics from 160 samples. Seer's special expertise is in nanoparticles, which are used to enrich proteins. The surface structure of the nanoparticles allows for protein enrichment without prior knowledge of the proteins to be enriched, making them suitable for a wide range of samples. In comparative studies, Seer's method has proven to be reproducible and unique in terms of performance. Seer's reagents are not available from others, and its closest competitors are not suitable for e.g. cell lysate samples. These combined unique properties are related to the particles: • Enrichment of low-abundance and previously undetected proteins. • Compatibility and demonstrated increase in the number of identified proteins from a wide range of samples including serum, plasma, cell culture media, and cell lysates. • Compatibility with samples from different species These properties distinguish Seer's method from affinity proteomics solutions of other possible provider´s reagents, making it the only suitable solution for research in question: • Compatibility with non-human samples • Seer’s method can be integrated into existing mass spectrometry-based workflows in Turku Bioscience Centre • Turku Bioscience Centre´s previous research was performed also with Seer reagents and to ensure comparability, the reagents must be from the same source. Seer Proteograph reagents are proprietary and compatible with Seer Proteograph system, which is the only solution in the market that meets all the necessary technical requirements to fulfil the uncompromising needs of the acquiring department as previously described. Reagents are planned to be used together with Seer SP100 Automation Instrument. Seer reagents require a special Seer instrument, SP100 Automation Instrument with XT, the only compatible with previously listed reagents. The instrument has the locked software, which was developed by SEER. The robot itself is manufactured by Hamilton, but ready-made control software for performing the SEER Proteograph protocol is not available anywhere else. The method is complex, and among other things, utilizes barcoded information on reagent tubes and containers, so its implementation with some generic laboratory automation is not practically possible.

Contracting authorities1

UT

UNKNOWN 0245896-3

fiTurku, Finland
[email protected]

Lots1

Documentation0

The source system does not support document syncing.

Award criteria0

No procedure-level award criteria recorded.

Participants0

No participants recorded for this notice.